摘要1例74岁男性冠状动脉粥样硬化性心脏病患者于冠状动脉支架植入术后应用硫酸氢氯吡格雷、阿司匹林、通心络、辅酶Q10、阿托伐他汀钙、维生素E及维生素C。因降脂效果不达标，患者自行停用阿托伐他汀钙，改服瑞舒伐他汀钙10 mg，1次/d。随后4个月，患者血糖水平较前升高，空腹血糖波动于6.5~7.8 mmol/L，餐后血糖波动于7.7~10.5 mmol/L。7个月后，患者空腹血糖达11.5 mmol/L，餐后血糖达16.0 mmol/L，糖化血红蛋白9.6%。患者自行停用瑞舒伐他汀钙。3个月后，空腹血糖降至5.9 mmol/L，餐后血糖降至7.4 mmol/L，糖化血红蛋白降至6.6%。

abstractsA 74-year-old male patient with coronary atherosclerotic heart disease given clopidogrel hydrogen sulfate,aspirin,Tongxinluo(通心络),coenzyme Q10 ,atorvastatin calcium,vitamin E and vitamin C after undergoing coronary artery stent implantation. He stopped taking atorvastatin calcium because of the lipid-lowering effect was not good and switched to rosuvastatin calcium 10 mg once daily by himself. The patient's blood glucose level elevated within four months. His fasting blood glucose ranged from 6. 5 to 7. 8 mmol/L and postprandial blood glucose ranged from 7. 7 to 10. 5 mmol/L. Seven months later,his fasting blood glucose peaked at 11. 5 mmol/L,and postprandial blood glucose peaked at 16. 0 mmol/L, glycosylated hemoglobin level was 9. 6%. He discontinued rosuvastatin calcium by himself. Three months later,the fasting blood glucose and postprandial blood glucose were down to 5. 9 mmol/L and 7. 4 mmol/L, glycosylated hemoglobin level was back to 6. 6%.